Also trades as: CERO (OTC) · $vol 0M
CEROW OTC
CERo Therapeutics Holdings, Inc.
1W: -45.1%
1M: +94.5%
3M: -71.5%
YTD: -57.2%
1Y: -88.0%
$0.00
+0.00 (+18.89%)
Weekly Expected Move ±256.2%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
14 relationships14
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-10-12
Earliest Filing
2024-02-28
Latest Filing
partner: 5
investor: 4
target: 4
acquirer: 1
Counterparties (Filed by CEROW)
14 relationshipsCompanies named in CEROW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Arena Business Solutions Global SPC II, Ltd | AREN | investor | Committed to purchase up to $25 million of the Company's common stock under a purchase agreement. | 2024-02-28 | View |
| CERo Therapeutics, Inc. | CEROW | target | Target company in the business combination agreement and PIPE financing. | 2024-02-06 | View |
| PBCE Merger Sub, Inc. | — | partner | Merger subsidiary entity entering into the business combination agreement. | 2024-02-06 | View |
| Continental Stock Transfer and Trust Company | — | partner | Trustee entering into Trust Agreement Amendment to extend business combination period | 2024-01-05 | View |
| CERo Therapeutics, Inc. | CEROW | target | Target company in proposed business combination | 2023-12-11 | View |
| PBCE Merger Sub, Inc. | — | target | Merger subsidiary in proposed business combination | 2023-12-11 | View |
| Continental Stock Transfer and Trust Company | — | partner | Trustee entering into an amendment to the Investment Management Trust Agreement to extend the business combination perio | 2023-07-10 | View |
| CERo Therapeutics, Inc. | CEROW | target | Target company in the business combination agreement to be merged with Merger Sub. | 2023-06-05 | View |
| PBCE Merger Sub, Inc. | — | acquirer | Special purpose merger subsidiary of Phoenix Biotech Acquisition Corp. used to acquire CERo Therapeutics. | 2023-06-05 | View |
| Cantor Fitzgerald & Co. | — | partner | Representative of underwriters in the IPO and purchaser of Placement Units | 2021-10-12 | View |
| Continental Stock Transfer & Trust Company | — | partner | Trustee for the trust account and transfer agent | 2021-10-12 | View |
| Phoenix Biotech Sponsor, LLC | — | investor | Sponsor purchasing Placement Units and providing administrative services | 2021-10-12 | View |
| Cohen & Company Capital Markets | COHN | investor | Division of J.V.B. Financial Group, LLC purchasing Placement Units | 2021-10-12 | View |
| J.V.B. Financial Group, LLC | — | investor | Parent company of Cohen & Company Capital Markets purchasing Placement Units | 2021-10-12 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-31 | Material Agreement; Termination of Agreement; Financial Obligation; Unregistered Equity Sales; Exhib | Agreement | View |
| 2026-07-17 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-06-26 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-05-29 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-05-01 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-04-14 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-03-11 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2026-02-13 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2026-02-04 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-03 | Notice of Delisting or Transfer | View | |
| 2026-01-07 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-12-19 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-12-02 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-10-30 | Notice of Delisting or Transfer; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-16 | Entry into Material Definitive Agreement; Amendments to Articles of Incorporation or Bylaws; Other E | Agreement | View |
| 2025-10-14 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-09-22 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-09-05 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-04 | Notice of Delisting or Transfer | View | |
| 2025-07-18 | Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR